P1521: IMPROVED CLINICAL OUTCOME OF COVID-19 IN HAEMATOLOGIC MALIGNANCY PATIENTS RECEIVING A FOURTH DOSE OF ANTI-SARS-COV-2 VACCINE: AN EPICOVIDEHA REPORT

P1521: IMPROVED CLINICAL OUTCOME OF COVID-19 IN HAEMATOLOGIC MALIGNANCY PATIENTS RECEIVING A FOURTH DOSE OF ANTI-SARS-COV-2 VACCINE: AN EPICOVIDEHA REPORT

Bibliographic Details
Main Authors:	Jon Salmanton-García, Francesco Marchesi, Andreas Glenthøj, Yavuz M. Bilgin, Jens VAN Praet, Julio Dávila-Valls, Sonia Martín-Pérez, Jorge Labrador, Jaap Van Doesum, Iker Falces-Romero, Francesca Farina, Martin Schönlein, Caroline Besson, Verena Petzer, Ildefonso Espigado, Michelina Dargenio, Avinash Aujayeb, Uluhan Sili, Laura Serrano, Laszlo Imre Pinczes, Nick de Jonge, Andrés Soto-Silva, Caterina Buquicchio, Lucia Prezioso, Monia Marchetti, Stef Meers, Alessandro Busca, Paolo Corradini, Martin Hoenigl, Philipp Koehler, Laman Rahimli, Gökçe Melis Çolak, Elena Arellano, Dominik Wolf, Stefanie Gräfe, Emanuele Ammatuna, Caroline Berg Venemyr, Oliver A. Cornely, Livio Pagano
Format:	Article
Language:	English
Published:	Wiley 2023-08-01
Series:	HemaSphere
Online Access:	http://journals.lww.com/10.1097/01.HS9.0000972964.65137.d1

Similar Items

Improved Clinical Outcome of COVID-19 in Hematologic Malignancy Patients Receiving a Fourth Dose of Anti-SARS-CoV-2 Vaccine: An EPICOVIDEHA Report
by: Jon Salmanton-García, et al.
Published: (2022-11-01)

Passive pre-exposure immunization by tixagevimab/cilgavimab in patients with hematological malignancy and COVID-19: matched-paired analysis in the EPICOVIDEHA registry
by: Francesco Marchesi, et al.
Published: (2023-04-01)

S292: NIRMATRELVIR/RITONAVIR IN COVID-19 PATIENTS WITH HAEMATOLOGICAL MALIGNANCIES: A REPORT FROMTHE EPICOVIDEHA REGISTRY
by: Jon Salmanton-García, et al.
Published: (2023-08-01)

EPICOVIDEHA: A Ready to Use Platform for Epidemiological Studies in Hematological Patients With COVID-19
by: Jon Salmanton-García, et al.
Published: (2021-07-01)

Outcome of COVID-19 in allogeneic stem cell transplant recipients: Results from the EPICOVIDEHA registry
by: Alessandro Busca, et al.
Published: (2023-02-01)

P1514: MOLNUPIRAVIR COMPARED TO NIRMATRELVIR/RITONAVIR FOR COVID-19 IN HIGH-RISK PATIENTS WITH HAEMATOLOGICAL MALIGNANCY IN EUROPE. A MATCHED-PAIRED ANALYSIS FROM THE EPICOVIDEHA REGISTRY
by: Jon Salmanton-García, et al.
Published: (2023-08-01)

Unveiling the Hidden Burden: From EPICOVIDEHA to EPIFLUEHA, Exploring the Epidemiology of Respiratory Viral Infections in Hematological Patients
by: Jon Salmanton-García, et al.
Published: (2023-11-01)

B-cell malignancies treated with targeted drugs and SARS-CoV-2 infection: A European Hematology Association Survey (EPICOVIDEHA)
by: Maria Stefania Infante, et al.
Published: (2022-10-01)

Outcomes of SARS-CoV-2 infection in Ph-neg chronic myeloproliferative neoplasms: results from the EPICOVIDEHA registry
by: Monia Marchetti, et al.
Published: (2023-03-01)

Dexamethasone treatment for COVID-19 is related to increased mortality in hematologic malignancy patients: results from the EPICOVIDEHA Registry
by: Tommaso Francesco Aiello, et al.
Published: (2024-04-01)

Nirmatrelvir/ritonavir in COVID-19 patients with haematological malignancies: a report from the EPICOVIDEHA registryResearch in context
by: Jon Salmanton-García, et al.
Published: (2023-04-01)

P1607: EPICOVIDEHA KIDS: A READY TO USE PLATFORM FOR EPIDEMIOLOGICAL STUDIES IN PEDIATRIC HEMATOLOGICAL PATIENTS WITH COVID-19
by: J. Salmanton-García, et al.
Published: (2022-06-01)

P55 MULTIPLE MYELOMA AND SARS-COV-2 INFECTION: AN EUROPEAN HEMATOLOGY ASSOCIATION SURVEY (EPICOVIDEHA) OF 1,221 PATIENTS THROUGH THE DIFFERENT PHASES OF COVID-19 PANDEMIC
by: P. Musto, et al.
Published: (2023-05-01)

COVID-19 infection in adult patients with hematological malignancies: a European Hematology Association Survey (EPICOVIDEHA)
by: Livio Pagano, et al.
Published: (2021-10-01)

Age, successive waves, immunization, and mortality in elderly COVID-19 hematological patients: EPICOVIDEHA findings
by: Giuseppe Rossi, et al.
Published: (2023-12-01)

S281: PRIOR EXPOSURE TO IMMUNOSUPPRESSIVE AGENTS AND COMORBIDITIES ARE ASSOCIATED WITH WORSE OUTCOMES OF SARS-COV2 INFECTION IN PH-NEG CHRONIC MYELOPROLIFERATIVE NEOPLASMS: RESULTS OF EPICOVIDEHA SURVEY
by: M. Marchetti, et al.
Published: (2022-06-01)

COVID-19 in adult acute myeloid leukemia patients: a long-term follow-up study from the European Hematology Association survey (EPICOVIDEHA)
by: Francesco Marchesi, et al.
Published: (2022-05-01)

MOLNUPIRAVIR (MOL) COMPARADO A NIRMATRELVIR/RITONAVIR (NIRI) PARA COVID-19 EM PACIENTES DE ALTO RISCO COM MALIGNIDADE HEMATOLÓGICA NA EUROPA: UMA ANÁLISE PAREADA DO REGISTRO EPICOVIDEHA
by: Jon Salmanton-García, et al.
Published: (2023-10-01)

NIRMATRELVIR/RITONAVIR (NIRI) EM PACIENTES COM COVID-19 E MALIGNIDADES HEMATOLÓGICAS: RELATO DO EPICOVIDEHA (REGISTRO INTERNACIONAL ONLINE DE PACIENTES COM MALIGNIDADES HEMATOLÓGICAS, INFECTADOS POR SARS-COV-2)
by: Jon Salmanton-García, et al.
Published: (2023-10-01)

S280: B-CELL MALIGNANCIES TREATED WITH TARGETED DRUGS AND SARS-COV-2 INFECTION. A EUROPEAN HEMATOLOGY ASSOCIATION SURVEY (EPICOVIDEHA)
by: M. S. Infante, et al.
Published: (2022-06-01)

MELHOR DESFECHO CLÍNICO DA COVID-19 EM PACIENTES COM MALIGNIDADE HEMATOLÓGICA QUE RECEBERAM UMA QUARTA DOSE DA VACINA ANTI-SARS-COV-2: EPICOVIDEHA (REGISTRO INTERNACIONAL ONLINE DE PACIENTES COM MALIGNIDADES HEMATOLÓGICAS, INFECTADOS POR SARS-COV-2)
by: Jon Salmanton-Garcia, et al.
Published: (2023-10-01)

Decoding the historical tale: COVID-19 impact on haematological malignancy patients—EPICOVIDEHA insights from 2020 to 2022Research in context
by: Jon Salmanton-García, et al.
Published: (2024-05-01)

CAPACIDADE LABORATORIAL PARA DIAGNOSTICAR E TRATAR INFECÇÕES FÚNGICAS INVASIVAS NA EUROPA: RESULTADOS DE UMA PESQUISA DA CONFEDERAÇÃO EUROPEIA DE MICOLOGIA MÉDICA (ECMM)
by: Jon Salmanton-Garcia, et al.
Published: (2023-10-01)

Necrotizing pancreatitis with invasive candidiasis and candidemia due to Candida albicans and pan-echinocandin-resistant Candida glabrata
by: Laman Rahimli, et al.
Published: (2024-03-01)

Tiempo de Penumbra: España, 1500-1521
by: Juan Manuel CARRETERO ZAMORA
Published: (2009-12-01)

РАТОВИ И СТАНОВНИШТВО УГАРСКЕ 1521-1718.
by: Золтан Ђере
Published: (2016-06-01)

Tiempo de Penumbra: España, 1500-1521
by: Juan Manuel CARRETERO ZAMORA
Published: (2009-12-01)

EHA Endorsement of the Global Guideline for the Diagnosis and Management of Rare Mold Infection: An Initiative of the European Confederation of Medical Mycology in Cooperation With International Society for Human and Animal Mycology and American Society for Microbiology
by: Rosanne Sprute, et al.
Published: (2021-03-01)

10th Trends in Medical Mycology Held on 8 to 11 October 2021, Aberdeen, Scotland, Organized by the European Confederation of Medical Mycology (ECMM)
by: Oliver A. Cornely, et al.
Published: (2021-10-01)

Mexican agriculture 1521-1630 : transformation of the mode of production /
by: 297031 Frank, Andre Gunder
Published: (1979)

A sülyi Szent Anna-kápolna alapítása (1521)
by: Balázs Csiba
Published: (2022-01-01)

Jayadewata dan Prasasti Kebantenan (1428-1521 Masehi)
by: Richadiana Kartakusuma
Published: (1994-05-01)

Jayadewata dan Prasasti Kebantenan (1428-1521 Masehi)
by: Richadiana Kartakusuma
Published: (1994-05-01)

Jayadewata dan Prasasti Kebantenan (1428-1521 Masehi)
by: Richadiana Kartakusuma
Published: (1994-05-01)

PB2586: PASSIVE PREEXPOSURE IMMUNIZATION BY TIXAGEVIMAB/CILGAVIMAB IN COVID 19 INFECTED HEMATOLOGICAL MALIGNANCY OF EPICOVIDHEA SURVEY
by: Caterina Buquicchio, et al.
Published: (2023-08-01)

Portuguese plain architecture : between spices and diamonds, 1521-1706 /
by: 198637 Kubler, George
Published: (1972)

Sincretismo, religión y arquitectura en Mesoamérica (1521-1571)
by: Jordi Gussinyer i Alfonso
Published: (1996-01-01)

Legitimación y religión en la revuelta de las Comunidades de Castilla (1520-1521) = Legitimation and Religion in the Revolt of the Comunidades of Castile (1520-1521)
by: Claudio César Rizzuto
Published: (2020-12-01)

Notes sur un témoignage inédit : les ricordi du « Libro debitori e creditori » de Giuliano da Gagliano (1503-1521)
by: Agnès Pallini-Martin
Published: (2016-08-01)

Comment to “Dexamethasone treatment for COVID-19 is related to increased mortality in hematologic malignancy patients: results from the EPICOVIDEHA Registry”
by: Guangting Zeng, et al.
Published: (2024-05-01)